Cargando…

Mapping Neutralizing Antibody Epitope Specificities to an HIV Env Trimer in Immunized and in Infected Rhesus Macaques

BG505 SOSIP is a well-characterized near-native recombinant HIV Envelope (Env) trimer that holds promise as part of a sequential HIV immunogen regimen to induce broadly neutralizing antibodies (bnAbs). Rhesus macaques are considered the most appropriate pre-clinical animal model for monitoring antib...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Fangzhu, Joyce, Collin, Burns, Alison, Nogal, Bartek, Cottrell, Christopher A., Ramos, Alejandra, Biddle, Trevor, Pauthner, Matthias, Nedellec, Rebecca, Qureshi, Huma, Mason, Rosemarie, Landais, Elise, Briney, Bryan, Ward, Andrew B., Burton, Dennis R., Sok, Devin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cell Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487785/
https://www.ncbi.nlm.nih.gov/pubmed/32905766
http://dx.doi.org/10.1016/j.celrep.2020.108122
_version_ 1783581559965614080
author Zhao, Fangzhu
Joyce, Collin
Burns, Alison
Nogal, Bartek
Cottrell, Christopher A.
Ramos, Alejandra
Biddle, Trevor
Pauthner, Matthias
Nedellec, Rebecca
Qureshi, Huma
Mason, Rosemarie
Landais, Elise
Briney, Bryan
Ward, Andrew B.
Burton, Dennis R.
Sok, Devin
author_facet Zhao, Fangzhu
Joyce, Collin
Burns, Alison
Nogal, Bartek
Cottrell, Christopher A.
Ramos, Alejandra
Biddle, Trevor
Pauthner, Matthias
Nedellec, Rebecca
Qureshi, Huma
Mason, Rosemarie
Landais, Elise
Briney, Bryan
Ward, Andrew B.
Burton, Dennis R.
Sok, Devin
author_sort Zhao, Fangzhu
collection PubMed
description BG505 SOSIP is a well-characterized near-native recombinant HIV Envelope (Env) trimer that holds promise as part of a sequential HIV immunogen regimen to induce broadly neutralizing antibodies (bnAbs). Rhesus macaques are considered the most appropriate pre-clinical animal model for monitoring antibody (Ab) responses. Accordingly, we report here the isolation of 45 BG505 autologous neutralizing antibodies (nAbs) with multiple specificities from SOSIP-immunized and BG505 SHIV-infected rhesus macaques. We associate the most potent neutralization with two epitopes: the C3/V5 and V1/V3 regions. We show that all of the nAbs bind in close proximity to known bnAb epitopes and might therefore sterically hinder elicitation of bnAbs. We also identify a “public clonotype” that targets the immunodominant C3/V5 nAb epitope, which suggests that common antibody rearrangements might help determine humoral responses to Env immunogens. The results highlight important considerations for vaccine design in anticipation of results of the BG505 SOSIP trimer in clinical trials.
format Online
Article
Text
id pubmed-7487785
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cell Press
record_format MEDLINE/PubMed
spelling pubmed-74877852020-09-18 Mapping Neutralizing Antibody Epitope Specificities to an HIV Env Trimer in Immunized and in Infected Rhesus Macaques Zhao, Fangzhu Joyce, Collin Burns, Alison Nogal, Bartek Cottrell, Christopher A. Ramos, Alejandra Biddle, Trevor Pauthner, Matthias Nedellec, Rebecca Qureshi, Huma Mason, Rosemarie Landais, Elise Briney, Bryan Ward, Andrew B. Burton, Dennis R. Sok, Devin Cell Rep Article BG505 SOSIP is a well-characterized near-native recombinant HIV Envelope (Env) trimer that holds promise as part of a sequential HIV immunogen regimen to induce broadly neutralizing antibodies (bnAbs). Rhesus macaques are considered the most appropriate pre-clinical animal model for monitoring antibody (Ab) responses. Accordingly, we report here the isolation of 45 BG505 autologous neutralizing antibodies (nAbs) with multiple specificities from SOSIP-immunized and BG505 SHIV-infected rhesus macaques. We associate the most potent neutralization with two epitopes: the C3/V5 and V1/V3 regions. We show that all of the nAbs bind in close proximity to known bnAb epitopes and might therefore sterically hinder elicitation of bnAbs. We also identify a “public clonotype” that targets the immunodominant C3/V5 nAb epitope, which suggests that common antibody rearrangements might help determine humoral responses to Env immunogens. The results highlight important considerations for vaccine design in anticipation of results of the BG505 SOSIP trimer in clinical trials. Cell Press 2020-09-08 /pmc/articles/PMC7487785/ /pubmed/32905766 http://dx.doi.org/10.1016/j.celrep.2020.108122 Text en © 2020 The Author(s) http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Zhao, Fangzhu
Joyce, Collin
Burns, Alison
Nogal, Bartek
Cottrell, Christopher A.
Ramos, Alejandra
Biddle, Trevor
Pauthner, Matthias
Nedellec, Rebecca
Qureshi, Huma
Mason, Rosemarie
Landais, Elise
Briney, Bryan
Ward, Andrew B.
Burton, Dennis R.
Sok, Devin
Mapping Neutralizing Antibody Epitope Specificities to an HIV Env Trimer in Immunized and in Infected Rhesus Macaques
title Mapping Neutralizing Antibody Epitope Specificities to an HIV Env Trimer in Immunized and in Infected Rhesus Macaques
title_full Mapping Neutralizing Antibody Epitope Specificities to an HIV Env Trimer in Immunized and in Infected Rhesus Macaques
title_fullStr Mapping Neutralizing Antibody Epitope Specificities to an HIV Env Trimer in Immunized and in Infected Rhesus Macaques
title_full_unstemmed Mapping Neutralizing Antibody Epitope Specificities to an HIV Env Trimer in Immunized and in Infected Rhesus Macaques
title_short Mapping Neutralizing Antibody Epitope Specificities to an HIV Env Trimer in Immunized and in Infected Rhesus Macaques
title_sort mapping neutralizing antibody epitope specificities to an hiv env trimer in immunized and in infected rhesus macaques
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487785/
https://www.ncbi.nlm.nih.gov/pubmed/32905766
http://dx.doi.org/10.1016/j.celrep.2020.108122
work_keys_str_mv AT zhaofangzhu mappingneutralizingantibodyepitopespecificitiestoanhivenvtrimerinimmunizedandininfectedrhesusmacaques
AT joycecollin mappingneutralizingantibodyepitopespecificitiestoanhivenvtrimerinimmunizedandininfectedrhesusmacaques
AT burnsalison mappingneutralizingantibodyepitopespecificitiestoanhivenvtrimerinimmunizedandininfectedrhesusmacaques
AT nogalbartek mappingneutralizingantibodyepitopespecificitiestoanhivenvtrimerinimmunizedandininfectedrhesusmacaques
AT cottrellchristophera mappingneutralizingantibodyepitopespecificitiestoanhivenvtrimerinimmunizedandininfectedrhesusmacaques
AT ramosalejandra mappingneutralizingantibodyepitopespecificitiestoanhivenvtrimerinimmunizedandininfectedrhesusmacaques
AT biddletrevor mappingneutralizingantibodyepitopespecificitiestoanhivenvtrimerinimmunizedandininfectedrhesusmacaques
AT pauthnermatthias mappingneutralizingantibodyepitopespecificitiestoanhivenvtrimerinimmunizedandininfectedrhesusmacaques
AT nedellecrebecca mappingneutralizingantibodyepitopespecificitiestoanhivenvtrimerinimmunizedandininfectedrhesusmacaques
AT qureshihuma mappingneutralizingantibodyepitopespecificitiestoanhivenvtrimerinimmunizedandininfectedrhesusmacaques
AT masonrosemarie mappingneutralizingantibodyepitopespecificitiestoanhivenvtrimerinimmunizedandininfectedrhesusmacaques
AT landaiselise mappingneutralizingantibodyepitopespecificitiestoanhivenvtrimerinimmunizedandininfectedrhesusmacaques
AT brineybryan mappingneutralizingantibodyepitopespecificitiestoanhivenvtrimerinimmunizedandininfectedrhesusmacaques
AT wardandrewb mappingneutralizingantibodyepitopespecificitiestoanhivenvtrimerinimmunizedandininfectedrhesusmacaques
AT burtondennisr mappingneutralizingantibodyepitopespecificitiestoanhivenvtrimerinimmunizedandininfectedrhesusmacaques
AT sokdevin mappingneutralizingantibodyepitopespecificitiestoanhivenvtrimerinimmunizedandininfectedrhesusmacaques